Latest Global Expansion News

Page 5 of 37
Schoolblazer Group has consolidated its fragmented debt into a $110 million multi-currency facility with Westpac, providing significant headroom for growth and lowering its cost of debt.
Victor Sage
Victor Sage
24 June 2026
AFT Pharmaceuticals surged 22% to NZ$254.7 million revenue in FY26, surpassing profit guidance and securing FDA approval to advance a pivotal injectable iron Phase III trial targeting a $7.4 billion market. The company is poised for further global expansion and product launches in FY27.
Ada Torres
Ada Torres
24 June 2026
AoFrio Limited has successfully closed a renounceable pro-rata rights issue, securing NZ$4.428 million to fund its push into US and European markets and advance AI-driven innovations in cold drink equipment.
Sophie Babbage
Sophie Babbage
24 June 2026
AFT Pharmaceuticals delivered a 22% revenue jump in FY26 to NZD 254.7 million, surpassing profit guidance and expanding its footprint to 87 countries. The company is advancing multiple R&D projects, including a pivotal Phase III injectable iron trial, while targeting over NZD 300 million in revenue for FY27.
Ada Torres
Ada Torres
24 June 2026
ClearVue Technologies has secured A$6 million through a $5 million institutional placement and a fully underwritten $1 million Share Purchase Plan, aiming to bolster its balance sheet and fund international expansion and product development.
Sophie Babbage
Sophie Babbage
22 June 2026
Memphasys has secured $1.2 million through a share placement to support the global expansion and manufacturing scale-up of its Felix™ sperm selection system. The company also extended a major convertible note, reinforcing financial flexibility amid growing international contracts.
Ada Torres
Ada Torres
18 June 2026
icetana AI has expanded its strategic partnership with SoftBank Robotics Group by signing a distribution agreement with SoftBank Robotics America, marking its entry into one of the world's largest security technology markets.
Sophie Babbage
Sophie Babbage
12 June 2026
TruScreen has secured clinical validation from the world’s largest cervical screening study in China, setting the stage for rapid market expansion across Asia, Africa, and Europe.
Ada Torres
Ada Torres
12 June 2026
Kingfish Limited's May update reveals a robust 5.5% portfolio return, driven by standout performances from Fisher & Paykel Healthcare and Infratil amid mixed sector headwinds.
Victor Sage
Victor Sage
12 June 2026
PolyNovo has completed its pivotal US clinical trial report for NovoSorb BTM and adjusted its FDA Premarket Approval submission timeline to late 2026 to incorporate updated regulatory requirements and additional data.
Ada Torres
Ada Torres
29 May 2026
EcoGraf confirms its patented HFfree process offers competitive costs for producing high-purity spherical graphite, targeting non-Chinese battery supply chains with plans for facilities in the US, Europe, and Asia.
Maxwell Dee
Maxwell Dee
29 May 2026
TruScreen Group reported a 42% increase in FY2026 sales driven by new market entries including India and Indonesia, alongside launching a large-scale cervical cancer screening program in Vietnam and submitting major UNITAID proposals.
Ada Torres
Ada Torres
29 May 2026

Browse the archive

Full archive